Alcoholism is a disease characterised by continuous heavy drinking. Until people with alcohol use disorder admit to problems with alcohol and stop drinking, the risk of alcohol use disorder continues which affects both physical and mental health.
Alcohol starts to injure the brain once it reaches the bloodstream.
Excessive consumption can lead to Alcohol-Related Brain Damage, or ARBD, which is a type of brain disorder caused by alcohol consumption. Brain shrinkage caused by alcohol abuse is permanent, as alcohol kills brain cells and grey matter.
For more information and effects click ‘Learn More’.
Every month, we bring you an unfiltered recovery conversation with someone who’s either experienced addiction firsthand, or works closely with those in recovery.
No sanitised success stories – just practical insights on what actually works in recovery, that you can apply, in your life too.
Recovery capital is the internal and external resource used to begin the recovery process and maintain sobriety. This combines personal, social, and community support to provide a joined-up approach that supports the addict through recovery.
Do you or a loved one need addiction treatment for alcohol or drugs? Thousands blindly walk into addiction treatment in expensive rehab centres and find that the reality doesn’t meet expectations.
If you’re considering rehab treatment, first check our ultimate guide for complete instructions on how to find the right rehab centre for you.
Take-home Naloxone kits help families and loved ones respond quickly in an opioid overdose emergency, until emergency services arrive. Kits contain nasal or injectable forms of Naloxone.
Changes in legislation mean Naloxone kits are now more widely available from pharmacies and drug services, including Abbeycare.
For additional information, click ‘Learn More’ below.
Overcoming alcohol addiction means first ceasing alcohol intake, and taking care of physical and chemical withdrawal symptoms.
Detoxing from alcohol means undergoing withdrawal from alcohol, but with the assistance of prescribed medication and detox phase, to substitute in place of the alcohol itself.
Alcohol rehab focuses on tackling the problems underneath alcoholism, such as grief, trauma, depression, and emotional difficulties, in order to reduce continuing drinking after treatment.
Inpatient services at an alcohol rehab programme provides 24 hour access to specialist care.
Alcohol home detox provides a means of semi-supervised addiction treatment in the comfort of your home. It’s often suitable for those with inescapable practical commitments, or where a reduced budget for treatment is available.
An at-home detox is the most basic detox option available from Abbeycare, and assumes you have support available, post-detox, for the other important elements of long-term addiction recovery.
The term alcoholism refers to the consumption of alcohol to the extent that the person is unable to manage their own drinking habits or patterns, resulting in side-effects that are detrimental to the quality of life and health of the alcoholic, or those around them.
An alcoholic is someone who continues to compulsively abuse alcohol in this way, despite the negative consequences to their lives and health.
Immediately following treatment, the early stages of recovery and abstinence are most vulnerable to lapses.
At Abbeycare, a structured and peer-reviewed aftercare plan is usually prepared whilst still in treatment. This comprises social, peer, and therapeutic resources individuals draw upon, following a residential treatment programme for drug or alcohol misuse.
Cognitive Behavioural Therapy is a well-known therapy option used by doctors at drug and alcohol treatment facilities for the treatment of substance use disorders.
It is a form of talking therapy that helps one mange their problems by changing how they think and behave. This form of therapy is used to treat depression and anxiety and is useful for physical health problems as well as one’s mental health.
Family Therapy at Abbeycare Scotland or Gloucester is realistic, compassionate, and appropriate for families and loved ones of addicts.
Family therapeutic interventions in residential rehabilitation have been designed to support those living with or caring for participants entering the Abbeycare Programme.
Support for families in a group setting allows for a safe, constructive, and confidential place to listen and share common experiences.
Inpatient rehab is drug and/ or alcohol treatment in a rehab centre, where patients remain on-site for the duration of inpatient rehabilitation.
It includes detoxification from drugs, therapy (group work and 1-2-1 sessions), and aftercare planning. Inpatient rehabs typically last 28 days, but this varies on an individual basis.
Long-term treatment at Abbeycare has been developed for those suffering from alcohol or drug addiction. Completing a long-term drug and alcohol inpatient programme may be the solution to problematic substance use.
Motivational Enhancement Therapy can be used by trained addiction recovery therapists to elicit internal changes within and promote long-term recovery from substance use disorder.
All the answers to addiction can be found within with this comprehensive and successful therapy concept leads to behavioural changes, reflective listening, self-motivational statements, and a comprehensive recovery process.
Outpatient drug or alcohol rehab is daytime treatment as opposed to living in a treatment facility.
Outpatient treatment is similar to inpatient in terms of the methods used to treat substance abuse. Where they differ is in their approach to recovery.
Abbeycare’s prison to rehab is a 12-week structured rehab programme which involves direct transfer from prison. The suitability of the candidate is decided by prison staff.
Short-term residential treatment programmes are the chance to press the reset button and access a therapeutic programme designed to create recovery from the use of alcohol and drugs.
Feeling stuck in a rut. Want to stop but can’t seem to achieve sobriety?
Click below.
The 12-step programme was created by alcoholics anonymous (AA), and is specifically designed to aid addicts in achieving and maintaining abstinence.
The central ethos behind the programme is that participants must admit and surrender to a divine power to live happy lives. Ideas and experiences are shared in meetings, and help is sought in an attempt to achieve abstinence.
Abbeycare’s policy to respect your privacy and comply with any applicable law and regulation regarding any personal information we may collect about you, including across our website and other sites we own and operate.
Our admissions team will explain the process of a symptom managed crystal meth detox before admission; you will be able to communicate any concerns or fears about the detox process.
Symptom monitoring is used instead of medication because there is no regulatory-approved medication for crystal meth.
Symptom monitoring and management primarily focuses on overcoming hallucinations, depression and poor sleep, and secondary medications are prescribed as necessary.
Appetite increases due to malnourishment in active use, so more calories are consumed to compensate for this loss.
On average, inpatients for meth addiction consume 8% more calories than those not in detox, so diets are monitored to ensure nutritional requirements are met [3].
Meth-induced psychotic episodes occur from months to years after the last use, so olanzapine is prescribed to stabilise patients in detox [4].
To manage poor cognitive functioning in meth withdrawal, modafinil is prescribed and improves memory recall scores by 59% compared to a placebo (4.5%) [2].
Detox Symptoms
At Abbeycare, our experienced clinical team are prepared for withdrawal symptoms that may occur during crystal meth detox, and treat them using symptom management methods.
Physiological Symptoms Of Detox
'Crashing' occurs due to a 38.4% reduction in dopamine transporters in the orbitofrontal cortex [1].
Increased appetite occurs due to reduced adrenoceptor binding 24 hours after cessation, leading to eating more [5].
A 0.58 ± 0.13 ng/mL reduction in orexin-A levels 1-2 months into abstinence exacerbates sleepiness and meth cravings [6].
Increased interleukin levels result in an inflammatory response, leading to agitation [7].
Psychological Symptoms Of Crystal Meth Detox
Experimental evidence evidences that a 15% reduction in glutamate levels in early abstinence leads to emotional dysregulation, such as extreme anger [8].
Psychotic episodes occur because the brain recompensates for lost dopamine, resulting in overstimulation.
70% of patients report thinking about using meth and experiencing cravings at the start of treatment [9].
Depression occurs in meth withdrawal, but the prevalence of symptoms subsides by 37.8% between weeks 1 and 2 of treatment [10].
Psychological cravings begin to subside after 5 weeks of detox [9].
27% of severe meth-induced psychotic patients present with co-occurring aggression [9].
Depleted levels of dopamine and norepinephrine, neurotransmitters responsible for alertness, result in insomnia.
A 27.8% mean reduction in striatal dopamine transporters in meth withdrawal patients results in poor memory, measured by the Auditory Verbal Learning Task, and brain fog [11].
Behavioural Symptoms Of Crystal Meth Detox
Dopamine receptors are reduced by 16.1% in the caudate nucleus in meth users, resulting in compulsive hair pulling and rocking back and forward [12].
Paranoid beliefs about being watched or followed are observed in detox due to 19% higher levels of glutamate in frontal brain matter, causing overstimulation [13].
Formication, or "meth mites", results from constricted blood vessels and delusional beliefs [14].
Animal studies demonstrate that a 35% decrease in dopamine levels results in compulsive and drug-seeking behaviour in early abstinence [15].
A 3.67% reduction in impulse inhibition results in erratic behaviour in short-term meth abstinence <10 months - this improves with length of treatment and abstinence [16].
Crystal Meth Detox Recovery Markers
Improving Cognitive Function
Attention improves by ~18% following 6 days of crystal meth detox compared to controls [17].
Improvements (~12.5%) in attention and psychomotor speed are maintained for 12 months following detox compared to no treatment [18].
Motor impulsivity improves by ~17% following 2 weeks of crystal meth detox, increasing to ~19% in 1 month of abstinence [19].
Impulse inhibition improves by ~4% from short-term (4-9 days) to long-term (1 month+) crystal meth abstinence [20].
Natural Dopamine Production
Crystal meth detox causes natural dopamine production as a result of the brain's regulatory response to the absence of crystal meth during abstinence [21].
Research suggests that most dopamine restoration occurs in days 1-3 of detox, as dopamine binding increases by 41% compared to 15% in days 7-21 [22].
Dopamine activity increases by 19% in the caudate and 16% in the putamen, brain areas responsible for motivation, following long-term abstinence (12 months) [23].
Neurological Stabilisation
Crystal meth detox leads to neurological stabilisation as a result of neurotransmitter regulation, leading to the resolution of psychotic symptoms within 10 days of detox [24].
Thalamic activity increases by 12% compared to before detox, indicating increases in brain metabolism during early abstinence [25].
In widespread dopaminergic damage, some patients experience hallucinations a few months after detox, though this can be managed appropriately with anti-psychotic medication and talking therapy.
It takes up to 35 months for neural restoration to be evident, though most patients see improvements in 2 weeks [26].
Meth mouth is known to affect treatment compliance and attendance to appointments, necessitating the need for inpatient care [27].
Immunocompromised cases of meth mouth require treatment in a hospital, as a weakened immune system is a risk factor for septicaemia.
Patients who injected meth are 2.47 times more likely to have dental disease than those who smoked, shifting the focus to nutritional care to prevent the spreading of the disease [28].
For patients who have recently become abstinent but used meth in the last 6 hours, dental treatment is deferred for 24 hours due to the use of local anaesthetic being contraindicated in this group [29].
Self Medicating Crystal Meth For Chronic Pain
Self-medicating meth for HIV-related pain causes a 2-fold increased risk of immunosuppression and further viral replication, requiring hospitalised treatment [30].
3 weeks of acupuncture reduces anxiety scores by 15%, reducing the need for diazepam for chronic pain patients in crystal meth withdrawal [31].
A 36% reduction in overall meth withdrawal symptoms through 3 weeks of acupuncture reduces the need for gabapentin for chronic pain patients [32].
Using acupuncture instead of pain medication in meth withdrawal eliminates side effects from analgesics, such as drowsiness, therefore making it easier to manage.
HIV patients need more information when using herbal remedies for depression during meth withdrawal, as St John's Wort reduces the blood plasma concentrations of Lopinavir [33].
Crystal Meth Induced Psychosis
25 mg intramuscular risperidone reduces the weekly average meth use by 75%, reducing the need for inpatient care when psychotic tendencies are present but addiction is mild [34].
The use of 8mg/day Perphenazine increases negative meth tests by 57% and enables those experiencing psychotic episodes to finish treatment as an outpatient if inpatient treatment becomes unsuitable [35].
Those experiencing psychotic episodes combined with violence in an inpatient facility require frequent clinical observations.
Co-occurring psychotic episodes with suicidal ideation require risk assessments to remove any ligature points or tools that could cause harm in a psychotic episode.
When Crystal Meth Detox Is Appropriate
Detoxification is appropriate when:
There is motivation for sobriety - this enables patients to meet addiction treatment demands
There is a clear history of meth or other stimulant relapse: this requires medical supervision and a comprehensive care plan
There is a family history of schizophrenia as this exacerbates meth-induced psychotic episodes when attempting abstinence without support
The patient is in a stable condition despite any medical or behavioural concerns
Psychotic episodes are apparent and are being treated with clozapine or other anti-psychotic medications
Aggression is evident as this is 1.81 times more likely to occur in meth addiction, disrupting self and others' quality of life [36]
Pregnant women are in a stable condition - in cases of pregnancy, hospitalised treatment is required due to the risk of pre-term birth
When Crystal Meth Detox Is NOT Appropriate
Detoxification is not appropriate when:
There are no signs of physical dependence or meth withdrawal symptoms
A patient is self-harming - 20.41% of meth users self-harm, worsening in detox due to tactile hallucinations and negative self-talk [37]
Co-occurring heart attacks occur as this requires urgent medical care in hospital
Experiencing a stroke as this requires emergency treatment, so detox cannot begin until the patient is stabilised
There is evident psychosis and suicidal ideation - anxiety induced by meth withdrawal worsens psychotic symptoms, so treatment is paused [38]
Crystal Meth Detox At Abbeycare
The Abbeycare detoxification programme lasts for 28 days and is offered as part of rehab.
At Abbeycare, each client is assessed individually before admission to gauge whether detox is appropriate or another programme is more suitable.
Comprehensive care plans consider triggers, physical symptoms and appropriate treatment options accordingly.
Please speak with our admissions team for further advice, on 01603 513 091.
About the author
Philippa Scammell
Philippa Scammell MSci holds an integrated Master's degree in Psychology
from the University of York and has completed undergraduate statistical studies at Harvard University. Philippa has substantial experience in inpatient psychiatric care (Foss Park Hospital York), Research in Psychology at University of York, and group therapy facilitation (Kyra Women's Project). Philippa writes on clinical psychology and addiction recovery. Content reviewed by Laura Morris (Clinical Lead).